211
Views
28
CrossRef citations to date
0
Altmetric
Research Article

Association of serum arginase I with oxidative stress in a healthy population

, , , &
Pages 147-155 | Received 08 Jul 2010, Published online: 13 Oct 2010

References

  • Jenkinson CP, Grody WW, Cederbaum SD. Comparative properties of arginase. Com Biochem Physiol B Biochem Mol Biol 1996;114:107–132.
  • Modolell M, Corraliza IM, Link F, Solar G, Eichmann K. Reciprocal regulation of the nitric oxide synthase /arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur J Immunol 1995;25:1101–1104.
  • Wang WW, Jenkinson CP, Griscavage JM, Kem RM, Arabolos NS, Byrns RE, Cederbaum SD, Igonarro LJ. Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide. Biochem Biophys Res Commun 1995;210:1009–1016.
  • Hey C, Boucher JL, Vadon-Le Goff S, Kettere G, Wessler I, Racke K. Inhibition of arginase in rat and rabbit alveolar macrophages by N omega-hydroxy-D, L-indospicine, effect on L-arginine utilization by nitric oxide synthase. Br J Pharmacol 1997;121:395–400.
  • Maarsingh H, Zaagsma J, Meurs H. Arginase: a key enzyme in the pathophysiology of allergic asthma opening novel therapeutic perspectives. Br J Pharmacol 2009;158:652–664.
  • Zimmermann N, King NE, Laprte J, Yang M, Mishra A, Pope SM, Muntel EE, Witte DP, Pegg AA, Foster PS, Hamid Q, Rotherberg ME. Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest 2003;111:1863–1874.
  • Takemoto K, Ogino K, Shibamori M, Hitomi Y, Takigawa T, Wang DH, Takaki JM Ichimura H, Ishiyama H. Transiently, paralleled upregulation of arginase and nitric oxide synthase and the effect of both enzymes on pathology of asthma. Am J Physiol Lung Cell Mol Physiol 2007;293:L1419–L1426.
  • Munder M, Mollinedo F, Calafat J, Canchado J, Gil-amaignere C, Fuentes JM, Luckner C, Doschoko G, Soler G, Eichmann K, Muller FM, Ho AD, Goerner M, Modolell M. Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. Blood 2009;105:2549–2556.
  • Morris CR, Poljakovic M, Lavrisha L, Mochando L, Kuypers FA, Morris SM, Jr. Decreased arginine bioavailability and increased serum arginase activity in asthma. Am J Respir Crit Care Med 2004;170:148–153.
  • Lara A, Khatri SB, Wang Z, Comhair SA, Xu W, Dweik RA, Bodine M, Levison BS, Hammel J, Bleecker E, Busse W, Calhoun WJ, Castro M, Chung KF, Curran-Evertt D, Gaston B, Israel E, Jaejour N, Moore W, Peters SP, Teague WG, Wenzel S, Hazen SL, Erzurum SC, National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Alterations of the arginine metabolome in asthma. Am J Respir Crit Care Med 2008;178:673–681.
  • Kocyigit A, Zeyrek D, Kekes H, Koylu A. Relationship among manganese, arginase, and nitric oxide in childhood asthma. Biol Trace Elem Res 2004;102:11–18.
  • Ceylan E, Aksoy N, Gencer M, Vyral H, Keles H, Selek S. Evaluation of oxidative-anitioxidative status and the L-arginine-nitric oxide pathway in asthmatic patients. Respir Med 2005;99:871–876.
  • Morris CR. Asthma management: reinventing the wheel in sickle cell disease. Am J Hematol 2009;84:234–241.
  • Morris CR, Kato GJ, Polijakovic M, Wang X, Blackweider WC, Sachdev V, Hazen SL, Vichinsky EP, Morris SM, Jr, Gladwin MT. Dysregulated arginine metabolism, hemolysis-assocated pulmonary hypertension, and mortality in sickle cell disease. JAMA 2005;294:81–90.
  • Leu SY, Wang SR. Clinical significance of arginase in colorectal cancer. Cancer 1992;70:733–736.
  • Rodriguez PC, Ernstoff MS, Hernndez C, Atkins M, Zabaleta J, Sieerra R, Ochoa AC. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res 2009; 69:1553–1560.
  • Wang SR, Chen ML, Huang MH, Lin HY, Tsai JJ, Kuo BIT. Plasma arginase concentration measured by an enzyme-linked immunosorbnt assay (ELISA) in normal adult population. Clin Biochem 1993;26:455–460.
  • Maarsingh H, Zaagsma J, Meurs H. Arginine homeostasis in allergic asthma. Eur J Pahrmacol 2008;585:375–384.
  • Munder M. Arginase: an emerging key player in the mammalian immune system. Br J Pharmacol 2009;158:638–651.
  • Bergeron C, Boulet LP, Page N, Laviolette M, Zimmermann N, Rothernberg ME, Hamid Q. Influence of cigarret smoke on the arginase pathway in asthmatic airways: increasesd expression of arginase I. J Allergy Clin Immunol 2007;119: 391–397.
  • Motran CC, Diaz FL, Gruppi A, Slavin D, Chatton B, Bocco JL. Human pregnancy-specific glycoprotein 1a (PSG1a) induces alternative activation in human and mouse monocytes and suppresses the accessory cell-dependent T cell proliferation. J Leukoc Biol 2002;72:512–521.
  • Gray MJ, Poljakovi M, Kepka-Lenhart D, Morris SM, Jr. Induction of arginase I transcription by IL-4 requires a composite DNA response element for STAT6 wnd C/EBPbeta. Gene 2000;353:98–106.
  • Halliwell B, Gutteridge JMC. Oxidative stress. Halliwell B, Gutteridge JMC. Free radical biology and medicine. 3rd. New York: Oxford University Press; 1999. 246–350.
  • Kimura S, Yamauchi H, Hibino Y, Iwamoto M, Sera K, Ogino K. Evaluation of urinary 8-hydroxydeoxtguanosine in healthy Japanese people. Basic Clin Pharmacol Toxicol 2006; 98:496–502.
  • Sakano N, Takahashi N, Wang DH, Sauriasari R, Takemoto K, Kannbara S, Sato Y, Takigawa T, Takaki J, Ogino K. Plasma 3-nitrotyrosine, urinary 8-isoprostane and 8-OHdG among healthy Japanese people. Free Radic Res 2009;43:183–192.
  • Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ, 2nd. A series of prostaglangin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free redical-catalyzed mechanism. Proc Natl Acad Sci USA 1990; 87:9383–9387.
  • Helmerson J, Basu S. F2-isoprostane excretion rate and diumal variation in human urine. Prostaglandins Leukot Essent Fatty Acids 1999;61:203–205.
  • Moller P, Loft S. Dietary antioxidants and beneficial effect on oxidatively damaged DNA. Free Radic Biol Med 2006;41: 388–415.
  • Banerjee D, Madhusoodanan UK, Nayak S, Jacob J. Urinary hydrogen peroxide: a probable marker of oxidative stress in malignancy. Clin Chim Acta 2003;334:205–209.
  • Yuen JW, Benzie IFF. Hydrogen peroxide in urine as a potential biomarkers of whole body oxidative stress. Free Radic Res 2003;37:1209–1213.
  • Wang SR, Chen ML, Huang MH, Lin HY, Tsai JJ, Kuo BIT. Plasma arginase concentration measured by an enzyme-linked immunosorbant asay (ELISA) in normal adult population. Clin Biochem 1993;26:455–460.
  • Morris CR, Suh JH, Hagar W, Laekin S, Bland DA, Steinberge MH, Vichinsky EP, Shigenaga M, Ames B, Kuypers FA, Lings ES. Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease. Blood 2008;111:402–410.
  • Matthiesen S, Lidemann D, Warnken M, Juergens UR, Racke K. Inhibition of NADPH oxidase by apocynin inhibits lipopolysaccharide (LPS) induced up-regulation of arginase in rat alveolar macrophages. Eur J Pharmacol 2008;579:403–410.
  • Thengchaisri N, Hei TW, Wang W, Xu X, Li Z, Fossum TW, Kuo L. Upregulation of arginase by H2O2 impairs endothelium-dependent nitric oxide-mediated dilatation of coronary arterioles. Arterioscler Thromb Vasc Biol 2006;26:2035–2042.
  • Muller JM, Rupec RA, Baeuerle PA. Study of gene regulation by NF-kappa B and AP-1 in response to reactive oxygen intermediates. Methods 1997;11:301–312.
  • Gius D, Botero A, Sha S, Curry HA. Intracellular oxidation/reduction ststus in the regulation of transcription factors NF-kappaB and AP-1. Toxicol Lett 1999;106:93–106.
  • Duffin R, Leitch AE, Fox S, Haslett C, Rossi AG. Targeting granulocyte apoptosis: mechanisms, models, and therapies. Immunol Rev 2010;236:28–40.
  • Bayne JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999;48:1–9.
  • Dandona P, Thusu S, Cook K, Synder B, Makowski J, Armstrong D, Nicotera T. Oxidative damage to DNA in diabetes mellitus. Lancet 1996;347:444–445.
  • Brownlee M. Biochemical and molecular cell biology of diabetic complications. Nature 2001;414:813–820.
  • Harriosn D, Griendling KK, Landmesser U, Horning B, Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol 2003;91:7A–11A.
  • Sakurai T, Tsuchiya S. Superoxide production from nonenzymatically glycated protein. FEBS Letters 1988;236: 406–410.
  • Kaneto H, Katakami N, Atsuhisa M, Matsuoka T. Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediat Inflamm 2010;2010:1–11.
  • Ikemoto M, Tsunekawa S, Awane M, Fukuda Y, Murayama H, Igarashi M, Nagata A, Kasai Y, Totani M. A useful ELISA system for human liver-type arginase, and its utility in diagnosis of liver disease. Clin Biochem 2001;34:455–461.
  • Morrow JD. Quantification of isoprostanes as induces of oxidant stress and the risk of atherosclerosis in humans. Arterioscler Thromb Vasc Biol 2005;25:279–286.
  • Michoulas A, Tong V, Teng XW, Chang TK, Abbott FS, Farrell K. Oxidative stress in children receiving valproic acid. J Pediatr 2006; 49:692–696.
  • Shibata H, Nabika T, Moriyama H, Masuda J, Kobayashi S. Correlation of NO metabolites and 8-iso-prostaglandin F2a with perivetricular hyperintensity severity. Arterioscler Thromb Vasc Biol 2004;24:1659–1663.
  • Devries MC, Hamadeh MJ, Glover AW, Raha S, Samjoo IA, Tranopolsky MA. Endurance training without weight loss loweres systemic, but not muscle, oxidative stress with no effect on inflammation in lean and obese women. Free Radic Biol Med 2004;45:503–511.
  • Davi G, Guagnano MT, Ciabattoni G, Basili S, Falco A, Marinopiccoli M, Nutini M, Sensi S, Patrono C. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA 2002;288:2008–2014.
  • Barden A, Zilkens RR, Croft K, Mori T, Burke V, Beilin IJ, Puddey IB. A reduction in alcohol consumption is associated with reduced plasma F2-isoprostanes and urinary 20-HETE excretion in men. Free Radic Biol Med 2007;42: 1730–1735.
  • Liang Y, Wei P, Duke RW, Reaven PD, Harman SM, Cutler RG, Heward CB. Quantification of 8-iso-prostaglamdin-F(2alpha) and 2,3-dinor-8-iso-prostaglndin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry. Free Radic Biol Med 2003;34:409–418.
  • Fenkel K, Zhoong ZJ, Wei HC, Kaekiszka J, Patel U, Rashid K, Georgescu M, Solomon JJ. Quantitative high-performance liquid chromatography analysis of DNA oxidized in vitro and in vivo. Anal Biochem 1991;196:126–136.
  • Saito S, Yamaguchi H, Hasui Y, Kurashige J, Ochi H, Yshida K. Quantitative determination of urinary 8-hydrosydeocy-guanosine (8-OH-dg) by using ELISA. Res Commun Mol pathol Pharmacol 2000;107:1664–1670.
  • Shimoi K, Kasai H, Yokota N, Toyokuni S, Kinae N. Comparison between high-performance liquid chromatography and enzyme-linked immunosorbant assay for the determination of 8-hydroxy-2′-deosyguanosine in human urine. Cancer Epidemiol Biomarkers Prev 2002;11:767–770.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.